MediaNewsPublicationsVideosAwareness CampaignsNewsPrintTweet12/09/2020A new study from Josep Carreras Institute reveals a new prognostic marker in a specific subtype of acute lymphoblastic leukemia (ALL) with adverse outcome in infantsMore11/25/2020Dr. Marcus Buschbeck leads the European Network INTERCEPT-MDS focusing on the shared training and research in Myeloid DiseasesMore09/15/2020The Josep Carreras Leukaemia Research Institute identifies a marker of poor evolution in Hodgkin's lymphomaMore08/12/2020A cancer mystery of more than forty years ago is solved thanks to EpigeneticsMore08/04/2020Identified gene mutations impact on the severity of a type of hematologic cancerMore07/27/2020Identified a new regulatory mechanism of response to metabolic stress that may be relevant for the treatment of leukemiaMore07/22/2020Dr. Manel Esteller awarded the Narcís Monturiol Medal for scientific and technological merit from the Government of CataloniaMore07/20/2020The Josep Carreras Institute creates a spin-off to develop therapies for leukaemia based on CAR–TMore07/08/2020Dr. Manel Esteller is recognized as the most cited biomedical scientist located in SpainMore07/01/2020Identified the genetic landscape of Myelodysplastic/Myeloproliferative NeoplasmsMoreFirstPrevious12345678910NextLastWebpage updated 10/16/2019 13:23:15
12/09/2020A new study from Josep Carreras Institute reveals a new prognostic marker in a specific subtype of acute lymphoblastic leukemia (ALL) with adverse outcome in infantsMore
11/25/2020Dr. Marcus Buschbeck leads the European Network INTERCEPT-MDS focusing on the shared training and research in Myeloid DiseasesMore
09/15/2020The Josep Carreras Leukaemia Research Institute identifies a marker of poor evolution in Hodgkin's lymphomaMore
07/27/2020Identified a new regulatory mechanism of response to metabolic stress that may be relevant for the treatment of leukemiaMore
07/22/2020Dr. Manel Esteller awarded the Narcís Monturiol Medal for scientific and technological merit from the Government of CataloniaMore
07/20/2020The Josep Carreras Institute creates a spin-off to develop therapies for leukaemia based on CAR–TMore
07/08/2020Dr. Manel Esteller is recognized as the most cited biomedical scientist located in SpainMore
José Carreras Leukaemia Foundation